Literature DB >> 17457563

[Vena cava filter].

T Helmberger1.   

Abstract

Fulminant pulmonary embolism is one of the major causes of death in the Western World. In most cases, deep leg and pelvic venous thrombosis are the cause. If an anticoagulant/thrombotic therapy is no longer possible or ineffective, a vena cava filter implant may be indicated if an embolism is threatening. Implantation of the filter is a simple and safe intervention. Nevertheless, it is necessary to take into consideration that the data base for determining the indications for this treatment are very limited. Currently, a reduction in the risk of thromboembolism with the use of filters of about 30%, of recurrences of almost 5% and fatal pulmonary embolism of 1% has been reported, with a risk of up to 20% of filter induced vena cava thrombosis.

Entities:  

Mesh:

Year:  2007        PMID: 17457563     DOI: 10.1007/s00117-007-1511-y

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  8 in total

1.  Filter complications and their management.

Authors:  L J Greenfield; M C Proctor
Journal:  Semin Vasc Surg       Date:  2000-09       Impact factor: 1.000

Review 2.  Complications of inferior vena cava filters.

Authors:  Charles S Joels; Ronald F Sing; B Todd Heniford
Journal:  Am Surg       Date:  2003-08       Impact factor: 0.688

3.  Evaluation of retrievability of the Gunther tulip vena cava filter.

Authors:  Takuji Yamagami; Takeharu Kato; Tatsuya Hirota; Rika Yoshimatsu; Tomohiro Matsumoto; Tsunehiko Nishimura
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Mar-Apr       Impact factor: 2.740

4.  A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism.

Authors:  Patrick Mismetti; Karine Rivron-Guillot; Sara Quenet; Hervé Décousus; Silvy Laporte; Magali Epinat; Fabrice Guy Barral
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

5.  A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants.

Authors:  Amanda J Ghanim; Constantine Daskalakis; David J Eschelman; Walter K Kraft
Journal:  J Thromb Thrombolysis       Date:  2007-03-24       Impact factor: 2.300

6.  Gunther Tulip retrievable inferior vena caval filters: indications, efficacy, retrieval, and complications.

Authors:  S Looby; M F Given; T Geoghegan; A McErlean; M J Lee
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Jan-Feb       Impact factor: 2.740

7.  PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery.

Authors:  M Martin
Journal:  Clin Investig       Date:  1993-06

8.  Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients.

Authors:  Giancarlo Piano; Erika R Ketteler; Vivek Prachand; Erin Devalk; Thuong G Van Ha; Bruce L Gewertz; John C Alverdy
Journal:  J Vasc Surg       Date:  2007-04       Impact factor: 4.268

  8 in total
  1 in total

1.  [Vena cava filter. Which indications remain in the era of differentiated anticoagulation?].

Authors:  A H Mahnken
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.